Benign neonatal seizures
Benign Neonatal Seizures (BNS), also known as Benign Familial Neonatal Seizures (BFNS) when there is a family history, are a type of seizures occurring in newborn infants. These seizures are considered benign because they have a limited duration, typically occurring between the second and eighth day of life, and infants usually outgrow them without developing long-term neurological deficits or epilepsy.
Etiology and Pathophysiology[edit | edit source]
The exact cause of BNS is not fully understood, but it is believed to involve genetic factors. Mutations in the genes KCNQ2 and KCNQ3, which encode for potassium channel subunits, have been identified in many cases of BFNS. These channels are crucial for the regulation of neuronal excitability, and mutations can lead to increased neuronal firing, resulting in seizures.
Clinical Presentation[edit | edit source]
Infants with BNS experience seizures that are often characterized by apnea (pauses in breathing), tonic (stiffening) or clonic (jerking) movements of the limbs, and ocular movements such as blinking or staring. These seizures are generally brief but can occur multiple times a day while the condition persists.
Diagnosis[edit | edit source]
Diagnosis of BNS is based on the clinical presentation and the exclusion of other causes of neonatal seizures. Electroencephalogram (EEG) findings during this period may show characteristic patterns that support the diagnosis. Genetic testing can identify mutations in KCNQ2 or KCNQ3, confirming a diagnosis of BFNS.
Treatment[edit | edit source]
Treatment of BNS may not always be necessary, as the condition typically resolves on its own within weeks to months. However, in cases where seizures are frequent or severe, antiepileptic drugs (AEDs) may be used temporarily to control seizures. It is important to monitor infants for potential side effects of these medications.
Prognosis[edit | edit source]
The prognosis for infants with BNS is generally excellent. Most infants outgrow the seizures without any developmental delays or neurological issues. However, a small percentage may develop epilepsy later in life, necessitating ongoing monitoring.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD